文献速递乳腺癌

结构性种族主义与黑人及白人乳腺癌患者的治疗延迟

Structural Racism and Treatment Delay Among Black and White Patients With Breast Cancer.
PubMed 文献 · J Clin Oncol · 2024-08-06

研究基于北卡罗来纳州中央癌症登记处2004至2017年确诊的32,095例I至III期乳腺癌患者,构建县级结构性种族主义综合指数(SRCI),采用多水平logistic回归分析其与治疗延迟的关联。结果显示,黑人患者SRCI每增加10单位,治疗延迟的调整比值比(aOR)为1.25(95%置信限1.08至1.45);白人患者未见此关联(OR 1.05,95%置信限0.97至1.15)。结论认为,地区层面结构性种族主义与黑人乳腺癌患者治疗延迟几率升高相关,且与黑白人种治疗延迟差异扩大相关。

要点

  • 黑人患者SRCI每增加10单位,治疗延迟aOR为1.25(95%CL 1.08至1.45)。
  • 白人患者SRCI与治疗延迟无显著关联(OR 1.05,95%CL 0.97至1.15)。
  • 县级SRCI升高与黑人-白人治疗延迟差异扩大相关。

核心结论

  • 以复合指数测量的地区层面结构性种族主义与黑人乳腺癌患者治疗延迟几率升高相关,而与白人患者无此关联。
  • 县级结构性种族主义水平升高与黑人-白人治疗延迟差异扩大相关。

研究设计与样本

  • 队列研究,纳入北卡罗来纳州中央癌症登记处2004至2017年确诊的I至III期乳腺癌患者32,095例,并链接至多支付方保险索赔数据。
  • 县级数据来自罗伯特·伍德·约翰逊县级健康排名数据库汇总的多个公共来源。
  • 在县级量化五个领域八项社会决定因素的种族差距,按0至100最小-最大量表排名,各领域得分平均生成结构性种族主义综合指数(SRCI)评分。
  • 采用带随机截距和多个跨层交互项的多水平logistic回归,评估县级SRCI与患者层面治疗延迟的关联,调整患者层面特征并按种族分层。

主要发现

  • SRCI评分范围为21至75,中位数(四分位距)为39.0(31.8,45.7)。
  • 黑人患者中,SRCI评分每增加10单位与治疗延迟几率升高相关(aOR 1.25;95%CL 1.08至1.45)。
  • 白人患者中未发现此关联(OR 1.05;95%CL 0.97至1.15)。

关键数值与推荐

  • SRCI评分范围为21至75,中位数(IQR)为39.0(31.8,45.7)。
  • 黑人患者SRCI每增加10单位,治疗延迟aOR为1.25(95%CL 1.08至1.45)。
  • 白人患者SRCI每增加10单位,治疗延迟OR为1.05(95%CL 0.97至1.15)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以完善结构性种族主义的测量,并检验其与其他癌症诊疗差异的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Structural racism (SR) is a potential driver of health disparities, but research quantifying its impacts on cancer outcomes has been limited. We aimed to develop a multidimensional county-level SR measure and to examine the association of SR with breast cancer (BC) treatment delays among Black and White patients. METHODS: The cohort included 32,095 individuals from the North Carolina Central Cancer Registry with stage I to III BC diagnosed between 2004 and 2017 and linked to multipayer insurance claims from the Cancer Information and Population Health Resource. County-level data were drawn from multiple public sources aggregated in the Robert Wood Johnson County Health Rankings database. Racial gaps in eight social determinants across five domains were quantified at the county level and ranked on a 0-100 minimum-maximum scale. Domain scores were averaged to create a SR Composite Index (SRCI) score. We used multilevel logistic regression with random intercepts and multiple cross-level interaction terms to evaluate the association between county-level SRCI and patient-level treatment delays, adjusting for patient-level characteristics and stratified by race. RESULTS: The SRCI score ranged from 21 to 75 with a median (IQR) of 39.0 (31.8, 45.7). For Black patients, a 10-unit increase in SRCI score was associated with increased odds of delay (Adjusted odds ratios [aOR], 1.25; 95% confidence limits [CL], 1.08 to 1.45). No such association was found for White patients (OR, 1.05; 95% CL, 0.97 to 1.15). CONCLUSION: Area-level SR measured by a composite index is associated with higher odds of BC treatment delays among Black, but not White patients. Increasing county-level SR is associated with increasing Black-White disparities in treatment delay. Further research is needed to refine the measurement of SR and to examine its association with other cancer care disparities.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Reeder-Hayes KE, Jackson BE, Kuo TM, et al. Structural Racism and Treatment Delay Among Black and White Patients With Breast Cancer. J Clin Oncol. 2024. PMID: 39106434. doi:10.1200/JCO.23.02483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。